FI116569B - Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä - Google Patents

Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä Download PDF

Info

Publication number
FI116569B
FI116569B FI961900A FI961900A FI116569B FI 116569 B FI116569 B FI 116569B FI 961900 A FI961900 A FI 961900A FI 961900 A FI961900 A FI 961900A FI 116569 B FI116569 B FI 116569B
Authority
FI
Finland
Prior art keywords
factor viii
membrane
ionic strength
ligands
fraction
Prior art date
Application number
FI961900A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI961900A0 (fi
FI961900A (fi
Inventor
Djuro Josic
Ales Strancar
Monika Andrea Stadler
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6501733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI116569(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of FI961900A0 publication Critical patent/FI961900A0/fi
Publication of FI961900A publication Critical patent/FI961900A/fi
Application granted granted Critical
Publication of FI116569B publication Critical patent/FI116569B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI961900A 1993-11-04 1996-05-03 Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä FI116569B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4337573A DE4337573C1 (de) 1993-11-04 1993-11-04 Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden
DE4337573 1993-11-04
PCT/EP1994/003258 WO1995012609A1 (de) 1993-11-04 1994-09-30 Verfahren zur herstellung einer virusinaktivierten faktor viii enthaltenden fraktion mittels chromatographischer methoden
EP9403258 1994-09-30

Publications (3)

Publication Number Publication Date
FI961900A0 FI961900A0 (fi) 1996-05-03
FI961900A FI961900A (fi) 1996-05-03
FI116569B true FI116569B (fi) 2005-12-30

Family

ID=6501733

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961900A FI116569B (fi) 1993-11-04 1996-05-03 Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä

Country Status (21)

Country Link
EP (1) EP0726907B1 (uk)
JP (1) JP3739788B2 (uk)
KR (1) KR960705841A (uk)
CN (1) CN1109045C (uk)
AT (1) ATE228533T1 (uk)
AU (1) AU687451B2 (uk)
CA (1) CA2175670C (uk)
CZ (1) CZ290186B6 (uk)
DE (2) DE4337573C1 (uk)
ES (1) ES2182846T3 (uk)
FI (1) FI116569B (uk)
HU (1) HU222087B1 (uk)
IL (1) IL111263A (uk)
MY (1) MY113294A (uk)
NO (1) NO317112B1 (uk)
PL (1) PL181725B1 (uk)
RU (1) RU2148411C1 (uk)
SK (1) SK284215B6 (uk)
UA (1) UA43855C2 (uk)
WO (1) WO1995012609A1 (uk)
ZA (1) ZA948667B (uk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19618851C1 (de) * 1996-05-10 1997-07-24 Octapharma Ag Verfahren zur Eignungsprüfung von Faktor VIII-haltigen Proteinfraktionen
AU1725297A (en) * 1996-03-08 1997-09-22 Octapharma Ag Process for testing suitability of protein fractions containing factor viii
ES2137878B1 (es) * 1997-12-01 2000-10-01 Grifols Grupo Sa Procedimiento de obtencion de un plasma humano atenuado de virus para uso terapeutico.
KR101804136B1 (ko) * 2008-06-24 2017-12-04 옥타파마 아게 응고 인자 ｖｉｉｉ을 정제하는 방법
WO2012082933A1 (en) 2010-12-15 2012-06-21 Baxter International, Inc. Eluate collection using conductivity gradient

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
JPS62191042A (ja) * 1986-02-17 1987-08-21 Kanegafuchi Chem Ind Co Ltd 血液凝固第８因子吸着体およびそれを用いた血液凝固第８因子の精製法
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
CA2001720C (en) * 1988-10-31 2001-10-02 Randal A. Goffe Membrane affinity apparatus and purification methods related thereto
EP0367840B1 (de) * 1988-11-05 1993-02-03 Octapharma AG Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie
CH678155A5 (uk) * 1989-08-09 1991-08-15 Fischer Ag Georg
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation

Also Published As

Publication number Publication date
WO1995012609A1 (de) 1995-05-11
PL314185A1 (en) 1996-09-02
CN1109045C (zh) 2003-05-21
IL111263A (en) 2000-07-16
ATE228533T1 (de) 2002-12-15
HU222087B1 (hu) 2003-04-28
ES2182846T3 (es) 2003-03-16
NO317112B1 (no) 2004-08-16
UA43855C2 (uk) 2002-01-15
HU9601192D0 (en) 1996-06-28
HUT76530A (en) 1997-09-29
MY113294A (en) 2002-01-31
JPH09504532A (ja) 1997-05-06
FI961900A0 (fi) 1996-05-03
SK284215B6 (sk) 2004-11-03
DE59410213D1 (de) 2003-01-09
JP3739788B2 (ja) 2006-01-25
CZ290186B6 (cs) 2002-06-12
ZA948667B (en) 1995-07-07
DE4337573C1 (de) 1995-05-18
FI961900A (fi) 1996-05-03
SK56696A3 (en) 1996-10-02
EP0726907B1 (de) 2002-11-27
NO961816D0 (no) 1996-05-03
PL181725B1 (pl) 2001-09-28
AU7810994A (en) 1995-05-23
KR960705841A (ko) 1996-11-08
CA2175670A1 (en) 1995-05-11
EP0726907A1 (de) 1996-08-21
CA2175670C (en) 2005-08-02
AU687451B2 (en) 1998-02-26
CN1134157A (zh) 1996-10-23
RU2148411C1 (ru) 2000-05-10
NO961816L (no) 1996-05-03
CZ118796A3 (en) 1996-12-11
IL111263A0 (en) 1994-12-29

Similar Documents

Publication Publication Date Title
US4673734A (en) Porous mineral support coated with an aminated polysaccharide polymer
US4138287A (en) Purifying and isolating method for hepatitis virus to use in preparing vaccine
CZ277939B6 (en) Process for preparing stable concentrate of a complex factor viii-von willebrand factor exhibiting high specific activity
FI116569B (fi) Menetelmä virusinaktivoidun, tekijä-VIII-pitoisen fraktion valmistamiseksi kromatografisilla menetelmillä
JPS60243097A (ja) 単クローン抗体の分離方法
US4247452A (en) Purification of pertussis haemagglutinins
KR100320394B1 (ko) 멤브레인크로마토그래피시켜비타민-k의존형단백질을정제시키는방법
Neidhardt et al. Rapid, two-step purification process for the preparation of pyrogen-free murine immunoglobulin G1 monoclonal antibodies
JPS6034916A (ja) 第１ｘ因子および他のビタミンｋ依存性タンパク質の高純度精製
US4189535A (en) Serum cell growth promoting materials
RU2145610C1 (ru) Способ очистки рекомбинантного эритропоэтина человека
CA2076557C (en) Process for the purification of factor xiii, monoclonal antibodies against factor xiiia, the preparation and use thereof
JP5089924B2 (ja) ＩｇＭ型抗体の精製方法、ＩｇＭ型抗体認識抗原の吸着材
CA1065305A (en) PROCESS FOR THE ENRICHMENT OF THE PREGNANCY-SPECIFIC .beta.1-GLYCOPROTEIN
JPH0459797A (ja) 抗体の精製法
RU2367449C1 (ru) Способ выделения и очистки трофобластического бета-1-гликопротеина
JPH05170799A (ja) ヒトインターロイキン８の精製方法
JPH01165393A (ja) 組換えヒトエリスロポエチンの精製方法
JPH11174038A (ja) 蛋白質の分離精製法
JPS58192827A (ja) 神経生長促進作用を有する新規物質
CZ2000983A3 (cs) Způsob čištění antithrombinu III

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116569

Country of ref document: FI